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It is widely believed that oxidative stress plays an impor-
tantroleinthepathogenesisoftypeIIdiabetes.Thepresent
studywasundertakentoexaminethefunctioningoftwoan-
tioxidant scavenger enzymes, superoxide dismutase (SOD)
and glutathione peroxidase (GSH-Px), in erythrocytes in a
population of healthy aging adult women compared with
a similar population with type II diabetes. Blood samples
were examined from 42 female adult healthy subjects at
different ages and from 59 female patients with type II di-
abetes. A signiﬁcant increase in SOD activities was corre-
lated with aging in erythrocytes of the healthy control sub-
jects (r= .550, P = .001); however, this correlation was
not found in subjects with type II diabetes (r = .250, P <
.07). A trend showing a reduction in glutathione peroxidase
activities was demonstrated with aging (r = −.331, P =
.228); however, this trend was not found in diabetic sub-
jects (r = .031, P< .820). The results indicate a possible
imbalance in the antioxidant system in erythrocytes of ag-
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elsewhere that investigated the correlation between SOD and GSH-Px
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ing adult women, which is even more pronounced in cases
of type II diabetes. This study may indicate possible thera-
peutic treatment or preventive measures to limit oxidative
damage and reduce complications of diabetes.
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Age-related degenerative changes affect a wide range of bi-
ological tissues. Accelerated aging changes that contribute to
early morbidity are common in type II diabetes mellitus (DM)
[1].Oxygenhomeostasis(prooxidantandantioxidant)isofcrit-
ical importance for maintaining tissue viability and function.
Oxidative stress involves imbalance between production of re-
active oxygen species (ROS) and their removal. Both humans
andexperimentalanimalsshowage-relatedincreasesofreactive
oxygen species, accompanied by changes in the system of an-
tioxidant (AO) scavengers [2]. Individuals with type II diabetes
show increased generation of ROS, eliciting both oxidative
stress and glycation [3, 4]. As a protective measure, many cells
and tissues in diabetic patients and experimental diabetic ani-
mals stimulate production of antioxidant enzymes such as su-
peroxide dismutase (SOD) and gluthathione peroxidase (GSH-
Px) [5–9]. Changes in the antioxidant system differ in various
tissues. High oxidative stress is common in organs and tissues
withhighmetabolicandenergydemands,includingskeletaland
heart muscle, liver, lymphatic organs, and blood cells. In dia-
betic subjects, SOD and GSH-Px activities in skeletal muscle,
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spleen, retina, and other tissues may be reduced [10], whereas
in other tissues, including kidneys and thymus, AO activities
are in fact increased. Changes in the functional capacities of
erythrocytes (RBCs) in human type II diabetes with aging have
proved ambiguous [11, 12]. The main aim of the present study
was to examine the functioning of two AO scavenger enzymes,
SOD and GSH-Px, in a population of healthy aging adults in
comparison with a similar age-matched population with type II
diabetes (non–insulin-dependent DM, NIDDM).
EXPERIMENTAL
Subjects and Methods
All participants in the study provided informed consent.
There were two study groups: (a) A type II diabetic group
with at least 3 years since onset of the condition, consisting
of59women;nosubjectrequiredinsulin.Theiragerangefrom
35 to 80, mean age 68 ± 7.4 from the Kupat Holim B Diabetes
Clinic, Ashdod, Israel; and (b) a control group of 42 healthy
women volunteers (age range 35 to 82, mean age 69.5± 7.1)
matched for age, body mass index (BMI), lipid values, blood
pressure (BP) (Table 1), and smoking status recruited from
the staff of the Harzfeld Geriatric Hospital, Jerusalem. Sub-
jects with dyslipidemia and under hormone replacement ther-
apy were excluded.
Two milliliters of blood were drawn from the cubital vein
of subjects after an overnight fast and collected in tubes con-
taining an anticlotting agent (KF-Natrium II, EDTA). To pre-
pare the samples of erythrocytes, the blood was centrifuged
at 1000 rpm for 7 minutes in a refrigerated centrifuge and
the plasma and buffy coat discarded, followed by washing of
erythrocytes in normal saline and further centrifugation for
10 minutes. Determination of erythrocyte SOD and GSH-Px
TABLE 1
Comparison of the healthy women parameters (mean ± SD)
Diabetic group Control group P
Variables (n = 59) (n = 42) values
Age (years) 68 ± 7.4 69.5 ± 7.1 NS
BMI NS
Cholesterol (total) 208.9 ± 26.4 206.6 ± 27.9 NS
Triglycerides 125.5 ± 34 128 ± 31 NS
SBPmax (mm Hg) 181.5 ± 17.2 184.8 ± 19.3 NS
DBPmax (mm Hg) 84.6 ± 11.7 85.2 ± 14.4 NS
Glycated 139.25 ± 5.1 95.08 ± 4.6 .001
hemoglobina
(mg/dL)
P <. 05. BMI = body mass index; SBPmax = maximal systolic
blood pressure; DBPmax = maximal diastolic blood pressure.
aFasting blood glucose in serum.
activities was based on the method described by Paglia and
Valentine[13].Brieﬂy,SODestimationwasbasedonthegener-
ationofsuperoxideradicalsproducedbyxanthineandxanthine
oxidase,whichreactwith2-(4-idophenel)-3-(4-nitrophenol)-5-
phenyltetrazolium chloride to form a red formazan dye. SOD
activitywasthenmeasuredbythedegreeofinhibitionofthisre-
action.GSH-Pxactivitywasbasedontheabilityofthisenzyme
to catalyze the oxidation of glutathione by cumen hydroperox-
ide. Kits from Sigma were used for the enzyme assays. In the
presence of glutathione reductase and NADPH, the oxidized
glutathione is immediately converted to the reduced form with
a concomitant oxidation of NADPH to NADP+. The decrease
in absorbance at 340 nm was measured using a Spectronic 401
spectrophotometer.
Protein was determined in diluted aliquots of the tissue ho-
mogenates by the method of Bradford [14].
Statistical Analysis
All statistical analyses were subjected to a 2-way analysis
of variance (ANOVA) using SPSS version 11, with the 2 main
factorsbeinghealthyandhavingdiabetestypeII.Totestforsig-
niﬁcant differences between means, a Fisher’s least signiﬁcant
difference test was used. P < .05 was accepted as signiﬁcant.
RESULTS
The results are presented in Table 2. There was signiﬁ-
cant differences (P < .001) in SOD activities between healthy
women and diabetic women, in all age categories, with total
mean SOD activities of 184 ± 17.3 and 118 ± 13.1 units/mg
protein, respectively. This differences were mainly because the
absence of the increment of SOD activity with age. SOD activ-
ity levels at different ages in healthy controls and the diabetic
(NIDDM) women are shown in Figure 1. Increasing SOD ac-
tivities in erythrocytes are correlated (r = from .541 to .561)
signiﬁcantly (P = .001) with increasing age in the healthy
control subjects, whereas such a correlation does not exist in
subjects with NIDDM (r = from .249 to .253, P < .066–.071).
The activity of GSH-Px in healthy women was from 1.02 up
to 1.58 units/mg protein (mean of 1.20 ± 0.13 units/mg pro-
tein) and from 0.63 to 1.35 units/mg protein (mean of 0.99 ±
0.11 units/mg protein) in diabetic women. Changes of GSH-Px
activities in different age groups among healthy and NIDDM
subjects are shown in Figure 2.
There was an age-related decrease in GSH-Px activities in
the healthy controls (r = from −.329 to −.335, P < .2); how-
ever, such a weak correlation was absent in the diabetic group
(r = .031, P < .8). No correlation (r =− .172) was found
between the above enzymes. The duration since the onset of
the diabetes did not affect the activities of SOD or GSH-Px. NoANTIOXIDANTS IN ERYTHROCYTES IN AGING AND DIABETES 173
TABLE 2
The values of SOD and GSH-Px and their correlation to age and diabetes
Age SOD GSH-Px
Group age No. mean ± SD (U/mg protein) rP (U/mg protein) rP
Healthy control
30–40
41–50
51–60
61–70
71–80
7
9
9
9
8
34 ± 2.2
46 ± 3.1
56 ± 2.8
67 ± 1.9
74 ± 3.0
99 ± 13.1
101 ± 15.8
160 ± 19.7
278 ± 18.9
282 ± 19.2
.556
.541
.553
.561
.558
∗.001
.001
.001
.001
.001
1.58 ± 0.16
1.21 ± 0.15
1.08 ± 0.12
1.02 ± 0.11
1.15 ± 0.12
.331
.329
.334
.332
.335
∗.228
.219
.230
.227
.229
Mean 184 ± 17.3 1.20 ± 0.13
Diabetes
30–40
41–50
51–60
61–70
71–80
9
12
14
10
14
35 ± 3.2
44 ± 3.3
55 ± 4.1
66 ± 2.1
74 ± 2.8
86 ± 11.2
144 ± 12.4
89 ± 11.6
140 ± 14.7
131 ± 15.5
.253
.256
.249
.251
.252
.070
.069
.071
.066
.069
0.79 ± 0.1
0.63 ± 0.17
1.17 ± 0.1
1.35 ± 0.1
1.04 ± 0.1
.031
.030
.033
.032
.030
.821
.818
.835
.810
.842
Mean 118 ± 13.1 0.99 ± 0.11
∗P signiﬁcant at <.05; r, correlation coefﬁcient.
correlationbetweenindicesofglycemia(glycatedhemoglobin)
and levels of SOD and GSH-Px was found in diabetic people.
DISCUSSION
The aim of this study was to determine the activity levels of
two AO scavenger enzymes in erythrocytes of adult-onset dia-
betics at different ages in comparison with age-, BMI-, lipids-,
and BP-matched healthy controls. Radicals are involved in di-
abetes and related to a malfunction of AOs. In healthy control
subjects the levels of SOD activities in erythrocytes showed
marked progressive increases with aging, especially after age
60, whereas in the diabetic individuals erythrocyte SOD activ-
ities were elevated to a much lesser degree with aging. On the
FIGURE 1
Superoxide dismutase (SOD) enzymatic activities with age in
erythrocytes of healthy controls compared with
type II diabetes.
other hand, the GSH-Px activity does not change with age but
ratheritisslightlydecreased,whereasinagedNIDDMsubjects
the activity of GSH-Px is increased. The increase of GSH-Px
activity in speciﬁc biological cells in DM has been previously
reported [10]. The increased production of radicals in diabetes
may be associated by the presence of transition metal related
to glycated proteins. As suggested before [12], glucose can be
broken down into its ﬁnal products and reduce cellular oxygen,
yielding free radicals. Thus, free radicals may be detoxiﬁed by
AO enzymes such as SOD or GSH-Px [15].
FIGURE 2
Glutathione peroxidase (GSH-Px) activities with age in
erythrocytes in healthy controls compared with
type II diabetics.174 E. CARMELI ET AL.
Twopossiblebiochemicalmechanismscanexplainourﬁnd-
ings: (a) GSH-Px is reduced by GSSG reductase, which is
NAPDH dependent, and (b) increase in GSH-Px may be com-
pensatory due to decrease in SOD activity in DM. Contrary
to the ﬁndings of Kesavulu et al. [16], we found no change in
GSH-PxbetweenNIDDMandinsulin-dependentDM(IDDM).
Inourstudywefoundatemporarychangeindifferentenzymes
activity.
Normally, erythrocytes contain enough AO enzymes such
as SOD and GSH-Px. Yet, the AO enzyme activities in young
and old diabetic individuals remained questionable. The total
activity levels of AO (i.e., chelating agents) of ceruloplasmin,
transferrin iron-binding capacity, RBC gluthathione, GSH-Px,
and RBC SOD were lower in young DM patients [17]. In early
(juvenile) DM in children, AO activity (GSH-Px, SOD) is in-
creased,demonstratingincreasedoxidativeactivity.InagedDM
subjects the AO activity is decreased [18].
Experimental diabetic rats show lower SOD in liver, kid-
ney, heart, muscle, and erythrocytes [10]. Nishida et al. [19]
demonstrated in experimental diabetes subjects a decrease of
CuZn-SOD in retina in RBCs. However, it is a reversible phe-
nomenon and within 3 days of insulin administration, the SOD
levels returned to normal. Loven et al. [20] indicated a de-
crease of both CuZn-SOD and Mn-SOD in renal cortex. Also
in this study the SOD levels returned to normal following
5 days of insulin treatment. Wohaieb et al. [21] also reported
that CuZn-SOD changes are reversible in liver, pancreas, and
kidney, but not in erythrocytes.
Saito et al. [22] and Bono et al. [11] demonstrated in hu-
mans no differences in SOD activities between NIDDM and
non-NIDDM subjects. Selenium plays a role in reducing the
oxidative stress associated with diabetes. A marked decreased
in GSH-Px levels in DM subjects might be inhibited by sele-
nium [23].
Our study did not ﬁnd correlation between AO enzymes
and the level of glucose following fasting. Kotake et al. [24]
demonstratedthatthedecreaseinactivityofCuZn-SODinery-
throcytes of diabetics is consistent with glycosylation of the
3 active sites of CuZn-SOD, without any effect of hyper-
glycemia on the concentration of CuZn-SOD. One possible
mechanisminvolvedintheAOactivityhastodowithadvanced
glucosylation end products (AGEs) in diabetes and aging [24].
The increased nonenzymatic glycation has provided the basis
of the linkage between DM and late complications in differ-
ent tissues [4]. Thus, glycation reaction may proceed further
to trigger oxidative stress, which leads to the accumulation of
brown products, known as AGEs. Glycation occurs only in the
presence of oxygen and the involvement of superoxide radicals
and hydrogen peroxide [25]. Arai et al. [26] demonstrated that
CuZn-SOD activity in erythrocytes of 31 humans was severely
impaired in DM due to accumulation of carboxymethyl lysine,
which is a major product of oxidative modiﬁcation of glycated
enzymes.IndiabetesRBCs,glycosylatedCuZn-SODishigher.
Incubation in vitro with glucose leads to glycosylation. The
SOD active site contains histidine 72, whereas lysine is located
at site 71, and glucose is connected to lysine residue to form
Schiff-baseresponse.Theproximityofthesitesmayexplainthe
inactivation of the SOD [27]. Antidiabetic treatment with Cap-
paris deciduas decreased lipid peroxidation, yet altered SOD
and catalase enzymes to reduce oxidative stress [28].
The intensiﬁcation of GSH-Px and SOD activities in the
present study may conﬁrm the idea of a signiﬁcant contribu-
tion of AOs to impaired homeostasis under diabetic conditions.
Theiractivityisnotnecessarilyage-relatedbutratherglycemic-
related response.
CONCLUSIONS
Thepurposeofourstudywastoassesstheparametersoftwo
AOenzymesinRBCsofyoungandoldNIIDMandnondiabetic
women.
The activity level of superoxide dismutase and glutathione
peroxidase in RBCs is correlated to age but only in nondiabetic
women.ThelackofcorrelationinNIDDMmayindicatesapos-
sibleimbalanceintheAOsysteminerythrocytesofagingadult
women, which is even more pronounced in cases of type II dia-
betes. This study may suggest a possible therapeutic treatment
or preventive measures to limit oxidative damage and reduce
complications of diabetes.
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